T. Rowe Price Associates’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-881
Closed -$10K 2893
2023
Q1
$10K Hold
881
﹤0.01% 2880
2022
Q4
$8K Hold
881
﹤0.01% 2905
2022
Q3
$14K Buy
+881
New +$25.6K ﹤0.01% 2925

Other funds holding ATER

T. Rowe Price Associates's ATER Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Aterian (ATER) in Q2 2023, closing a stake of 881 shares — an estimated $10K sold.

T. Rowe Price Associates first reported a position in ATER in Q3 2022 and held it in 3 quarters. The position peaked at $14K in Q3 2022. 62 funds tracked by Wall St. Rank hold ATER as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Aterian position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 881 Aterian shares in Q2 2023, an estimated $10K.
  • T. Rowe Price Associates first reported a position in Aterian in Q3 2022 and held it in 3 quarters.
  • T. Rowe Price Associates's Aterian position peaked at $14K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Aterian as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.